Presented during Myotonic's Friday Afternoon Webinar Series.

This webinar presents an overview of multi-systemic aspects in DM2, including an update on cognitive deficits, CNS imaging techniques, coping with COVID-19 and DM2, and a research update emphasizing molecular mechanisms which could assist in better prognosis of DM2.

About the Presenter:

Giovanni Meola, MD
Università degli Studi di Milano

Dr. Meola is a clinician who has been interested in the field of neuromuscular disorders since 1975. In particular he is an expert in the diagnosis and management of myotonic dystrophies and non-dystrophic myotonias. He is the chairman of the neuromuscular center at IRCCS Policlinico San Donato, the national referral center for myotonic dystrophies and in particular for DM2. As a researcher, he developed the diagnosis of DM2 on muscle biopsy by FISH and on muscle channelopathies by specific clinical and genetic protocols. He has been the keynote lecturer and chairman at several international meetings, including IDMC.